SCHEMBL7105545

SCHEMBL7105545

O=C(NCCc1ccc(O)c(O)c1)NCCc1ccc(O)c(O)c1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.74
HSD17B10 Q99714 3/20 0.74
HIF1A Q16665 2/20 0.74
KDM4E B2RXH2 2/20 0.74
ALDH1A1 P00352 2/20 0.74
LMNA P02545 2/20 0.74
HPGD P15428 2/20 0.74
BLM P54132 2/20 0.74
PTGS1 P23219 1/20 0.74
ALOX15 P16050 2/20 0.61
TP53 P04637 1/20 0.61
CYP1A2 P05177 1/20 0.61
TSHR P16473 1/20 0.61
NFKB1 P19838 1/20 0.61
MAPK1 P28482 1/20 0.61
THPO P40225 1/20 0.61
APP P05067 1/20 0.60
GMNN O75496 1/20 0.59
GFER P55789 1/20 0.59
PMP22 Q01453 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL138689 0.93 MAPT (0.66) MAPTHSD17B10HIF1AKDM4EALDH1A1
SCHEMBL1709974 0.90 MAPT (0.71) MAPTHSD17B10HIF1AKDM4EALDH1A1
SCHEMBL30252290 0.90 MAPT (0.66) MAPTHSD17B10HIF1AKDM4EALDH1A1
SCHEMBL109163 0.89 MAPT (0.74) MAPTHSD17B10HIF1AKDM4EALDH1A1
SCHEMBL6420228 0.87 MAPT (0.72) MAPTHSD17B10HIF1AKDM4EALDH1A1
SCHEMBL107176 0.87 MAPT (0.62) MAPTHSD17B10HIF1AKDM4EALDH1A1
SCHEMBL7108607 0.86 MAPT (0.73) MAPTHSD17B10HIF1AKDM4EALDH1A1
SCHEMBL1278764 0.86 MAPT (0.73) MAPTHSD17B10HIF1AKDM4EALDH1A1
SCHEMBL25380895 0.85 MAPT (0.70) MAPTHSD17B10HIF1AKDM4EALDH1A1
SCHEMBL109158 0.85 MAPT (0.73) MAPTHSD17B10HIF1AKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030069307-A1 2-(3,4-Dihydroxyphenyl)ethyl-substituted carbonic acid derivatives and their use HAARMANN & REIMER GMBH (DE) 2003-04-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030069307-A1 2-(3,4-Dihydroxyphenyl)ethyl-substituted carbonic acid derivatives and their use NFE2L2, AGER, ME2 MAPT 2276/4885HSD17B10 1254/4885HIF1A 126/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.